Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (14)

2018

  1. Improved in vitro corneal delivery of a thrombospondin-1-derived peptide using a liposomal formulation

    Experimental Eye Research, Vol. 167, pp. 118-121

  2. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation

    International Journal of Pharmaceutics, Vol. 546, Núm. 1-2, pp. 20-30

2017

  1. Designing lipid nanoparticles for topical ocular drug delivery

    International Journal of Pharmaceutics, Vol. 532, Núm. 1, pp. 204-217

2014

  1. Nanoparticles based on naturally-occurring biopolymers as versatile delivery platforms for delicate bioactive molecules: An application for ocular gene silencing

    International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 12-20

2013

  1. A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model

    Gene Therapy, Vol. 20, Núm. 5, pp. 467-477

2011

  1. Activation of MAPK signaling pathway and NF-κB activation in pterygium and ipsilateral pterygium-free conjunctival specimens

    Investigative Ophthalmology and Visual Science, Vol. 52, Núm. 8, pp. 5842-5852

  2. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles

    Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788

  3. Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells

    Molecular Vision, Vol. 17, pp. 279-290

2010

  1. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles

    Cornea, Vol. 29, Núm. 5, pp. 550-558

2007

  1. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)

    Biomaterials, Vol. 28, Núm. 8, pp. 1553-1564

2006

  1. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance

    Investigative Ophthalmology and Visual Science, Vol. 47, Núm. 4, pp. 1416-1425

2004

  1. Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity

    Pharmaceutical Research, Vol. 21, Núm. 5, pp. 803-810

1998

  1. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat

    Current Eye Research, Vol. 17, Núm. 1, pp. 39-46

1996

  1. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A

    Pharmaceutical Research, Vol. 13, Núm. 2, pp. 311-315